APPLICATION
ANDA074226
TYPE
ANDA
ORIGINAL APPROVAL
1994-05-10
LATEST ACTION
2017-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
GLIPIZIDEPrescription
GLIPIZIDE 10MG · TABLET · ORAL
GLIPIZIDEPrescription
GLIPIZIDE 5MG · TABLET · ORAL
Approval history
2017-04-11Labeling · Supplement 14 · standardAP
2017-04-11Labeling · Supplement 15 · standardAP
2013-07-26Labeling · Supplement 12 · standardAP
2009-05-19Labeling · Supplement 10AP
2001-09-25Labeling · Supplement 3AP
2000-03-24Labeling · Supplement 2AP
1998-02-05Manufacturing (CMC) · Supplement 1AP
1994-05-10OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.